Key facts
- This page summarizes Leni Boeren's Form 4 filing for RENOVARO BIOSCIENCES INC. (RENB).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 25 Oct 2023, 10:56.
Leni Boeren - 04 Oct 2023 Form 4 Insider Report for RENOVARO BIOSCIENCES INC. (RENB)
- Reporting relationship
- Director
- Issuer ticker
- RENB
- Reported as of
- 04 Oct 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Oct 2023, 10:56:02 UTC
- Next SEC filing
- 17 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Leni M.T. Boeren
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Leni Boeren filed Form 4 for RENOVARO BIOSCIENCES INC. (RENB) on 25 Oct 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RENB
transaction
Derivative
Option to purchase shares of common stock
Award
- Transaction value
- $0
- Shares
- +16,129
- Change %
- Price
- $0.000000
- Shares after
- 16,129
- Date
- 04 Oct 2023
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 16,129
- Exercise price
- $4.65
* marks a reported price that did not pass the local price check.